PH vs WHWK · P/E 28, rev $21.50B vs $202.8M cap
Parker-Hannifin Corporation (PH) versus Whitehawk Therapeutics, Inc. (WHWK) — a side-by-side from cached financials, not a winner call.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Whitehawk Therapeutics, Inc. (WHWK) is a biotechnology company listed on NASDAQ.
Latest reported PH revenue for 2026-06-30 was $21.50B. Net income was $3.65B. Revenue was up 8.3% from 2025-06-30 to 2026-06-30. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Latest reported WHWK revenue for 2026-06-30 was $0. Net income was -$38.8M. WHWK currently screens at market cap $202.8M.
PH currently screens at market cap $91.89B and trailing P/E 27.7. WHWK currently screens at market cap $202.8M.
Not investment advice. Open the PH and WHWK stock pages for the full models.
Not investment advice.